Propeller Health announced that the FDA has granted 510(k) clearance for the company's inhaler monitoring sensor for AstraZeneca's Symbicort MDI. The Propeller sensor snaps on to the inhaler and connects via Bluetooth to a mobile app. The company also manufactures sensors for MDIs, DPIs, and SMIs made by GSK, Novartis, Orion, and Boehringer Ingelheim. Propeller … [Read more...] about Propeller Health sensor for Symbicort gets 510(k) clearance
Products and Services
iCAIR consortium initiates project to develop inhaled drugs for COVID-19
A consortium called Fraunhofer International Consortium for Anti-Infective Research (iCAIR) -- composed of researchers from Fraunhofer ITEM, Griffith University, Hannover Medical School, and Twincore -- has announced that it has initiated a project to develop inhaled drugs to treat COVID-19, starting with high-throughput screening for candidates by temporary … [Read more...] about iCAIR consortium initiates project to develop inhaled drugs for COVID-19
Proveris Scientific now offering cGMP compliant laboratory services for OINDPs
Spray characterization specialist Proveris Scientific has announced that it is now offering contract testing services for OINDP regulatory submissions, release testing and stability studies, as well as for development projects. The company received ISO 9001:2015 certification in 2018, and the laboratory now also meets cGMP requirements for both the FDA and the … [Read more...] about Proveris Scientific now offering cGMP compliant laboratory services for OINDPs
Nanoform gets GMP certification
The Finnish Medicines Agency has granted GMP certification to nanonization specialist Nanoform Finland, the company said. In December 2019, Nanoform announced that it had applied for the certification. The company's CESS (controlled expansion of supercritical solutions) nanoparticle engineering platform will now be available for manufacturing of clinical trial … [Read more...] about Nanoform gets GMP certification
3M Drug Delivery Systems becomes Kindeva Drug Delivery
3M announced that it has completed the sale of "substantially all" of 3M Drug Delivery Systems to Altaris Capital Partners, and the new company is now known as Kindeva Drug Delivery. The initial announcement of the sale was made in December 2019. Kindeva issued a separate press release announcing its launch as "a leading global contract development and … [Read more...] about 3M Drug Delivery Systems becomes Kindeva Drug Delivery
Fluidda study suggests that inhaled vasodilators may be helpful in COVID-19
Functional respiratory imaging (FRI) company Fluidda has announced that an FRI study of COVID-19 patients has shown that the virus is resulting in narrowing of small capillaries in the lung, resulting in higher flow pressures that in turn causes higher pressure in the main blood vessels and suggests that vasodilators delivered to the lung may be a useful therapy. … [Read more...] about Fluidda study suggests that inhaled vasodilators may be helpful in COVID-19
Monaghan Medical will market Adherium’s Hailie inhaler monitoring platform in the US
Following the signing of a letter of intent for a sales agreement with Adherium, Monaghan Medical said that it will launch Adherium’s Hailie digital inhaler monitoring platform in the US. The Hailie sensor was approved by the FDA for US over the counter sales in July 2018, and Adherium launched the sensor in August of that year. Monaghan's parent company, Trudell … [Read more...] about Monaghan Medical will market Adherium’s Hailie inhaler monitoring platform in the US
MedPharm adds respiratory tissue culture models to aid in development of coronavirus therapies
CDMO MedPharm announced that it has added human epithelial cell models for screening of drugs intended for the treatment of coronaviruses at its facility in Durham, North Carolina, US. The company says that use of the nasal, bronchial, and alveolar models "will help to de-risk development programs and screen drugs for therapeutic effectiveness to accelerate … [Read more...] about MedPharm adds respiratory tissue culture models to aid in development of coronavirus therapies
Inhalation Sciences sells its remaining shares in spinoff Ziccum
Inhalation Sciences (ISAB) announced that it has sold all of its remaining shares in its spinoff Ziccum AB, a spray drying specialist, for a total of approximately SEK 21.2 million. In May 2019, ISAB announced that it was selling 40,000 shares of Ziccum to finance a study necessary to validate its PreciseInhale dosing system for clinical use. With the sale of the … [Read more...] about Inhalation Sciences sells its remaining shares in spinoff Ziccum
Alpha Cognition and Linical partner on potential intranasal therapy for Alzheimer’s disease
Alpha Cognition Inc. (formerly Neurodyn Cognition) and CRO Linical have announced Linical will provide consulting services related to potential development of Alpha Cognition's Alpha-1062 acetyl choline esterase inhibitor (AChEI) for the treatment of Alzheimer's disease. Linical's services are expected to encompass a range of areas, including regulatory guidance, … [Read more...] about Alpha Cognition and Linical partner on potential intranasal therapy for Alzheimer’s disease